| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 16.547 | 23.184 | 28.269 | 20.714 | 11.745 | 13.678 | 17.414 | 33.754 | 25.574 |
| Total Income - EUR | - | 16.547 | 23.184 | 28.269 | 20.714 | 11.745 | 13.678 | 17.414 | 33.755 | 25.574 |
| Total Expenses - EUR | - | 3.117 | 7.224 | 3.683 | 4.713 | 2.625 | 3.211 | 5.383 | 6.905 | 9.257 |
| Gross Profit/Loss - EUR | - | 13.431 | 15.959 | 24.586 | 16.001 | 9.120 | 10.468 | 12.031 | 26.850 | 16.317 |
| Net Profit/Loss - EUR | - | 12.934 | 15.264 | 23.738 | 15.380 | 8.786 | 10.057 | 11.509 | 22.482 | 13.911 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Iripatri Med Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 639 | 394 | 1.746 | 4.545 | 3.654 | 9.435 | 7.984 | 10.310 | 8.677 |
| Current Assets | - | 12.614 | 15.846 | 23.074 | 11.188 | 20.535 | 4.794 | 3.797 | 13.492 | 16.134 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8 | 0 |
| Receivables | - | 853 | 635 | 0 | 27 | 4.651 | 0 | 0 | 840 | 1.128 |
| Cash | - | 11.761 | 15.211 | 23.074 | 11.161 | 15.884 | 4.794 | 3.797 | 12.644 | 15.007 |
| Shareholders Funds | - | 12.979 | 15.316 | 24.505 | 15.430 | 23.924 | 13.994 | 11.558 | 22.530 | 24.297 |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | 274 | 924 | 316 | 303 | 265 | 235 | 223 | 1.272 | 607 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Iripatri Med Srl